<DOC>
	<DOCNO>NCT02224794</DOCNO>
	<brief_summary>The primary objective LIFE Study demonstrate clinical cost benefit associate use Ovation® Abdominal Stent Graft Platform least invasive condition define Fast-Track EVAR protocol . The key element Fast-Track EVAR protocol include : appropriate patient selection , bilateral percutaneous access , general anesthesia , ICU admission post procedure , next day discharge .</brief_summary>
	<brief_title>LIFE Study : Least Invasive Fast-Track EVAR</brief_title>
	<detailed_description>The LIFE Study prospective , consecutively enrol , non-randomized multi center post-market registry evaluate ultra low profile ( 14F ) Ovation Abdominal Stent Graft Platform use Percutaneous Endovascular Aneurysm Repair ( P-EVAR ) treatment patient AAA use Fast-Track EVAR protocol . 250 study patient enrol 40 institution . Follow-up period one month .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Patient ≥ 18 year age . Patients male nonpregnant female ( female child bear potential must negative pregnancy test prior enrollment study ) . Patient sign IRB approve informed consent form . Patient consider treat physician candidate elective open surgical repair AAA . Patient infrarenal abdominal aortic aneurysm meet least one following : abdominal aortic aneurysm &gt; 5.0 cm diameter , aneurysm increase size 0.5 cm last 6 month , maximum diameter aneurysm exceed 1.5 time transverse dimension adjacent nonaneurysm exceed 1.5 time transverse dimension adjacent nonaneurysmal aortic segment . Patient suitable anatomy allow use TriVascular Ovation® Abdominal Stent Graft Platform . Patient suitable femoral artery percutaneous access site allow use Perclose ProGlide SutureMediated Closure System via preclose technique . Patient must willing comply require followup exam . Patient need emergent surgery . Patient dissect aneurysm . Patient acutely rupture aneurysm . Patient acute vascular injury . Patient previous repair abdominal aortic aneurysm iliac artery . Patient mycotic aneurysm active systemic infection . Patient unstable angina . Patient unstable peripheral artery disease critical limb ischemia . Patient congestive heart failure . Patient myocardial infarction and/or stroke within past 3 month . Patient require use technique would cover renal artery . Patient require plan adjunctive device complete procedure . Patient major surgical interventional procedure plan within ±30 day AAA repair . Patient history connective tissue disease . Patient history bleed disorder refuse blood transfusion . Patient dialysis dependent renal failure baseline serum creatinine level &gt; 2.0mg/dl . Patient known hypersensitivity contraindication anticoagulation contrast medium amenable pretreatment . Patient know allergy intolerance polytetrafluoroethylene ( PTFE ) , PEGbased polymer , fluorinated ethylene propylene ( FEP ) nitinol . Patient home oxygen . Patient morbidly obese ( BMI ≥40 kg/m2 ) . Patient admit skilled nursing facility . Patient limit life expectancy le 1 year . Patient inability discharge within 1 day procedure . Patient currently participate investigational device drug clinical trial . Patient medical , social psychological condition , opinion investigator , preclude receive pretreatment , require treatment , posttreatment procedure evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>abdominal</keyword>
	<keyword>aortic</keyword>
	<keyword>aneurysm</keyword>
</DOC>